Search research articles
Contact Us
Filters
Showing results (121-130 of 133) with videos related to
Page
of 14
Sort By:
Expert Review of Clinical Pharmacology
|
January 27, 2021
Clinical course of severe patients with COVID-19 treated with tocilizumab: report from a cohort study in Spain
Esther Chamorro-de-Vega, Carmen-Guadalupe Rodriguez-Gonzalez, Silvia Manrique-Rodríguez, et al.
Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases
|
July 1, 2021
Molecular epidemiological investigation of Mayaro virus in febrile patients from Goiania City, 2017-2018
Elisângela de Paula Silveira-Lacerda, Alice Laschuk Herlinger, Amilcar Tanuri, et al.
Microbiology Spectrum
|
April 27, 2022
Real-Life Use of Ceftolozane/Tazobactam for the Treatment of Bloodstream Infection Due to Pseudomonas aeruginosa in Neutropenic Hematologic Patients: a Matched Control Study (ZENITH Study)
Alba Bergas, Adaia Albasanz-Puig, Ana Fernández-Cruz, et al.
Blood Advances
|
April 14, 2023
Impact of SARS-CoV-2 vaccination and monoclonal antibodies on outcome post-CD19-directed CAR T-cell therapy: an EPICOVIDEHA survey
Jaap A van Doesum, Jon Salmanton-García, Francesco Marchesi, et al.
Frontiers in Immunology
|
March 13, 2023
Outcome of COVID-19 in allogeneic stem cell transplant recipients: Results from the EPICOVIDEHA registry
Alessandro Busca, Jon Salmanton-García, Francesco Marchesi, et al.
Frontiers in Oncology
|
October 24, 2022
B-cell malignancies treated with targeted drugs and SARS-CoV-2 infection: A European Hematology Association Survey (EPICOVIDEHA)
Maria Stefania Infante, Jon Salmanton-García, Ana Fernández-Cruz, et al.
Cancers
|
November 26, 2022
Simultaneous Onset of Haematological Malignancy and COVID: An Epicovideha Survey
Chiara Cattaneo, Jon Salmanton-García, Francesco Marchesi, et al.
Blood
|
September 20, 2022
Breakthrough COVID-19 in vaccinated patients with hematologic malignancies: results from the EPICOVIDEHA survey
Livio Pagano, Jon Salmanton-García, Francesco Marchesi, et al.
Hematological Oncology
|
December 5, 2023
Survival in multiple myeloma and SARS-COV-2 infection through the COVID-19 pandemic: Results from the EPICOVIDEHA registry
Pellegrino Musto, Jon Salmanton-García, Nicola Sgherza, et al.
Haematologica
|
May 12, 2022
COVID-19 in adult acute myeloid leukemia patients: a long-term follow-up study from the European Hematology Association survey (EPICOVIDEHA)
Francesco Marchesi, Jon Salmanton-García, Ziad Emarah, et al.
Page
of 14
Search research articles
Search
Showing results (121-130 of 133) with videos related to
Sort By:
Page
of 14
Expert Review of Clinical Pharmacology
|
January 27, 2021
Clinical course of severe patients with COVID-19 treated with tocilizumab: report from a cohort study in Spain
Esther Chamorro-de-Vega, Carmen-Guadalupe Rodriguez-Gonzalez, Silvia Manrique-Rodríguez, et al.
Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases
|
July 1, 2021
Molecular epidemiological investigation of Mayaro virus in febrile patients from Goiania City, 2017-2018
Elisângela de Paula Silveira-Lacerda, Alice Laschuk Herlinger, Amilcar Tanuri, et al.
Microbiology Spectrum
|
April 27, 2022
Real-Life Use of Ceftolozane/Tazobactam for the Treatment of Bloodstream Infection Due to Pseudomonas aeruginosa in Neutropenic Hematologic Patients: a Matched Control Study (ZENITH Study)
Alba Bergas, Adaia Albasanz-Puig, Ana Fernández-Cruz, et al.
Blood Advances
|
April 14, 2023
Impact of SARS-CoV-2 vaccination and monoclonal antibodies on outcome post-CD19-directed CAR T-cell therapy: an EPICOVIDEHA survey
Jaap A van Doesum, Jon Salmanton-García, Francesco Marchesi, et al.
Frontiers in Immunology
|
March 13, 2023
Outcome of COVID-19 in allogeneic stem cell transplant recipients: Results from the EPICOVIDEHA registry
Alessandro Busca, Jon Salmanton-García, Francesco Marchesi, et al.
Frontiers in Oncology
|
October 24, 2022
B-cell malignancies treated with targeted drugs and SARS-CoV-2 infection: A European Hematology Association Survey (EPICOVIDEHA)
Maria Stefania Infante, Jon Salmanton-García, Ana Fernández-Cruz, et al.
Cancers
|
November 26, 2022
Simultaneous Onset of Haematological Malignancy and COVID: An Epicovideha Survey
Chiara Cattaneo, Jon Salmanton-García, Francesco Marchesi, et al.
Blood
|
September 20, 2022
Breakthrough COVID-19 in vaccinated patients with hematologic malignancies: results from the EPICOVIDEHA survey
Livio Pagano, Jon Salmanton-García, Francesco Marchesi, et al.
Hematological Oncology
|
December 5, 2023
Survival in multiple myeloma and SARS-COV-2 infection through the COVID-19 pandemic: Results from the EPICOVIDEHA registry
Pellegrino Musto, Jon Salmanton-García, Nicola Sgherza, et al.
Haematologica
|
May 12, 2022
COVID-19 in adult acute myeloid leukemia patients: a long-term follow-up study from the European Hematology Association survey (EPICOVIDEHA)
Francesco Marchesi, Jon Salmanton-García, Ziad Emarah, et al.
Page
of 14